And while it widely known that NKX3.1 undergoes loss of heterozygosity because of deletions to the short arm of chromosome 8 [14,21], this event is not a focal deletion as is seen with traditional PCa tumor suppressors such as PTEN and TP53 [21]. The gene discussed is NKX3-1; the disease is posterior cortical atrophy.